Health benefits and economic advantages associated with increased utilization of a smoking cessation program
Publication: Journal of Comparative Effectiveness Research
Abstract
Rationale, aim & objective: The goal of this study was to examine the health and economic impacts related to increased utilization of the Duke Smoking Cessation Program resulting from the addition of two relatively new referral methods – Best Practice Advisory and Population Outreach. Materials & methods: In a companion paper ‘Comparison of Referral Methods into a Smoking Cessation Program’, we report results from a retrospective, observational, comparative effectiveness study comparing the impact of three referral methods – Traditional Referral, Best Practice Advisory and Population Outreach on utilization of the Duke Smoking Cessation Program. In this paper we take the next step in this comparative assessment by developing a Markov model to estimate the improvement in health and economic outcomes when two referral methods – Best Practice Advisory and Population Outreach – are added to Traditional Referral. Data used in this analysis were collected from Duke Primary Care and Disadvantaged Care clinics over a 1-year period (1 October 2017–30 September 2018). Results: The addition of two new referral methods – Best Practice Advisory and Population Outreach – to Traditional Referral increased the utilization of the Duke Smoking Cessation Program in Primary Care clinics from 129 to 329 smokers and in Disadvantaged Care clinics from 206 to 401 smokers. The addition of these referral methods was estimated to result in 967 life-years gained, 408 discounted quality-adjusted life-years saved and total discounted lifetime direct healthcare cost savings of US$46,376,285. Conclusion: Health systems may achieve increased patient health and decreased healthcare costs by adding Best Practice Advisory and Population Outreach strategies to refer patients to smoking cessation services.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
United States Surgeon General. The Health Consequences of Smoking – 50 years of progress (2014). www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf
2.
Centers for Disease Control and Prevention. Smoking and tobacco use; electronic cigarettes (2018). www.cdc.gov/tobacco/basic_information/e-cigarettes/
3.
Lortet-Tieulent J, Sauer AG, Siegel RL et al. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern. Med. 176(12), 1792–1798 (2016).
4.
Centers for Disease Control and Prevention. Smoking and Tobacco use; smokeless tobacco (2014). www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/index.htm
5.
Centers for Disease Control and Prevention. Economic trends in tobacco (2019). www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/index.htm
6.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Fifty years of change 1964–2014 (2014). www.ncbi.nlm.nih.gov/books/NBK294310/
7.
Centers for Disease Control and Prevention. Current cigarette smoking among adults in the United States (2019). www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm
8.
Centers for Disease Control and Prevention. Cigarette smoking and tobacco use among people of low socioeconomic status (2018). www.cdc.gov/tobacco/disparities/low-ses/
9.
Centers for Disease Control and Prevention. Burden of tobacco use in the US: current cigarette smoking among us adults aged 18 years and older (2019). www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html
10.
Centers for Disease Control and Prevention. Tobacco use and quitting among individuals with behavioral health conditions (2019). www.cdc.gov/tobacco/disparities/mental-illness-substance-use/index.htm
11.
National Alliance on Mental Illness. Tobacco and smoking. www.nami.org/learn-more/mental-health-public-policy/tobacco-and-smoking
12.
Christiansen B, Reeder K, Hill M, Baker TB, Fiore MC. Barriers to effective tobacco-dependence treatment for the very poor. J. Stud. Alcohol Drugs 73(6), 874–884 (2012).
13.
Stewart DW, Adams CE, Cano MA et al. Associations between health literacy and established predictors of smoking cessation. Am. J. Public Health 103(7), e43–e49 (2013).
14.
Trainor K, Leavey G. Barriers and facilitators to smoking cessation among people with severe mental illness: a critical appraisal of qualitative studies. Nicotine Tob. Res. 19(1), 14–23 (2017).
15.
Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99(1), 29–38 (2004).
16.
McDonough JE. The United States health system in transition. Health Syst. Ref. 1(1), 39–51 (2015).
17.
Institute of Medicine (US) Committee for the Study of the Future of Public Health. The Future of Public Health, Appendix A: Summary of the Public Health System in the United States. National Academies Press (US), www.ncbi.nlm.nih.gov/books/NBK218212/
18.
US Census Bureau. Health insurance coverage in the United States (2016). www.census.gov/library/publications/2017/demo/p60-260.html
19.
Committee on the Learning Health Care System in America, Institute of Medicine. A Continuously Learning Health Care System. Smith M, Saunders R, Stuckhardt Let al et al. (Eds). National Academies Press (US), www.ncbi.nlm.nih.gov/books/NBK207218/
20.
Curry SJ, Keller PA, Orleans CT, Fiore MC. The role of health care systems in increased tobacco cessation. Annu. Rev. Public Health 29, 411–428 (2008).
21.
Centers for Disease Control and Prevention. Smoking and tobacco use; state and community resources. www.cdc.gov/tobacco/stateandcommunity/index.htm
22.
Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs – 2014 (2018). www.cdc.gov/tobacco/stateandcommunity/best_practices/index.htm
23.
Centers for Disease Control and Prevention. Tobacco use screening and counseling during physician office visits among adults – National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005–2009. https://www.cdc.gov/mmwr/preview/mmwrhtml/su6102a7.htm
24.
Karam-Hage M, Oughli HA, Rabius V et al. Tobacco cessation treatment pathways for cancer patients: 10 years in the making models for smoking cessation practice. J. Natl Compr. Canc. Netw. 14(11), 1469–1477 (2016).
25.
Hays JT, Croghan IT, Schroeder DR et al. Residential treatment compared with outpatient treatment for tobacco use and dependence. Mayo Clin. Proc. 86(3), 203–209 (2011).
26.
Davis JM, Goldberg SB, Angel KS, Silver RH, Kragel EA, Lagrew DJ. Observational study on a mindfulness training for smokers within a smoking cessation program. Mindfulness (NY) 8(6), 1698 (2017).
27.
Atherton J. Development of the electronic health record. AMA J. Ethics 13(3), 186–189 (2011).
28.
Centers for Disease Control and Prevention. National Health Statistics Reports Number 115. 115, 9 (2018).
29.
Adoption of Electronic Health Record Systems among U.S. Non-federal acute care hospitals: 2008–2015 (2016). https://dashboard.healthit.gov/evaluations/data-briefs/non-federal-acute-care-hospital-ehr-adoption-2008-2015.php
30.
Fiore MC, Jorenby DE, Schensky AE, Smith SS, Bauer RR, Baker TB. Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clinic Proc. 70(3), 209–213 (1995).
31.
EHR Incentive Program. Eligible professional meaningful use core measures measure 9 of 13 stage 1(2014 definition) (2014). www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/9_Record_Smoking_Status.pdf
32.
Polubriaginof F, Salmasian H, Albert DA, Vawdrey DK. Challenges with collecting smoking status in electronic health records. AMIA Annu. Symp. Proc. 2017, 1392–1400 (2018).
33.
Lurio J, Morrison FP, Pichardo M et al. Using electronic health record alerts to provide public health situational awareness to clinicians. J. Am. Med. Inform. Assoc. 17(2), 217–219 (2010).
34.
Perri-Moore S, Kapsandoy S, Doyon K et al. Automated alerts and reminders targeting patients: a review of the literature. Patient Educ. Couns. 99(6), 953–959 (2016).
35.
Simon GE, Beck A, Rossom R et al. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial. Trials 17(1), 452 (2016).
36.
Haas JS, Linder JA, Park ER et al. Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial. JAMA Intern. Med. 175(2), 218–226 (2015).
37.
Danan ER, Fu SS, Clothier BA et al. the equity impact of proactive outreach to smokers: analysis of a randomized trial. Am. J. Prev. Med. 55(4), 506–516 (2018).
38.
Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford University Press, Oxford, UK (2006).
39.
Neumann PJ, Ganiats TG, Russell LB, Sanders GD, Siegel JE. (Eds). Cost–Effectiveness in Health and Medicine. Oxford University Press, Oxford, UK (2016).
40.
Sanders GD, Neumann PJ, Basu A et al. Recommendations for conduct, methodological practices and reporting of cost–effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 316(10), 1093–1103 (2016).
• A useful resource for conducting state-of-the-art cost–effectiveness economic analyses.
41.
Duke Smoking Cessation Program. Duke smoking cessation program clinic data. NC, USA
42.
US Department of Veterans Affairs. Pharmacy benefits management services (2020). www.pbm.va.gov/
43.
Centers for Medicare and Medicaid Services (2019). www.cms.gov/
44.
Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial. J. Clin. Psych. 76(10), e1285–e1291 (2015).
• An important source for the Markov model strategy and some of the parameter values used in the model.
45.
Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst. Rev. 5, CD009329 (2013).
•• An important source for the relative effectiveness of various smoking cessation interventions.
46.
Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: cochrane update of 2013 reviews. Addiction 109(9), 1414–1425 (2014).
47.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. 3, CD001292 (2017).
48.
Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 163(8), 622–634 (2015).
49.
Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the US Preventive Services Task Force. Ann. Intern. Med. 163(8), 608–621 (2015).
50.
Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict. Behav. 33(12), 1516–1520 (2008).
51.
Howard P, Knight C, Boler A, Baker C. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. Pharmacoeconomics 26(6), 497–511 (2008).
52.
Maciosek MV, Xu X, Butani AL, Pechacek TF. Smoking-attributable medical expenditures by age, sex and smoking status estimated using a relative risk approach. Prev. Med. 77, 162–167 (2015).
•• An important source of medical care costs of current versus former smokers.
53.
Vogl M, Wenig CM, Leidl R, Pokhrel S. Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 12(1), 203 (2012).
54.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. 3, CD001292 (2017).
55.
Office of Procurement, Acquisition and Logistics (OPAL). Pharmaceutical prices (2020). www.va.gov/opal/nac/fss/pharmPrices.asp
56.
Medicaid covered outpatient prescription drug reimbursement information by state (2020). www.medicaid.gov/medicaid/prescription-drugs/state-prescription-drug-resources/drug-reimbursement-information/index.html
57.
Quick guide: billing for smoking cessation counseling 99406 and 99407 (2016). https://capturebilling.com/how-bill-smoking-cessation-counseling-99406-99407/
58.
Sanders GD, Neumann PJ, Basu A et al. Recommendations for conduct, methodological practices and reporting of cost–effectiveness analyses: second panel on cost–effectiveness in health and medicine. JAMA 316(10), 1093–1103 (2016).
59.
Adsit RT, Fox BM, Tsiolis T et al. Using the electronic health record to connect primary care patients to evidence-based telephonic tobacco quitline services: a closed-loop demonstration project. Transl. Behav. Med. 4(3), 324–332 (2014).
60.
Thao V, Nyman JA, Nelson DB et al. Cost–effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial. Addiction 114(12), 2206–2216 (2019).
Information & Authors
Information
Published In
Pages: 817 - 828
PubMed: 32815740
Copyright
© 2020 James Davis and co-authors. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License
History
Received: 10 January 2020
Accepted: 5 June 2020
Published online: 20 August 2020
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Health benefits and economic advantages associated with increased utilization of a smoking cessation program. (2020) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2020-0005
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Olivia Allen, Lindsey Fields, Maura Sweeney, Shontel Als, William Seiple, Anurag Shrivastava, The Impact of Workflow Modifications in an Electronic Medical Record on Tertiary Service Referrals for Patients with Visual Impairment in New York City, Clinical Ophthalmology, 10.2147/OPTH.S532586, Volume 19, (3693-3702), (2025).
- Seyedeh Samaneh Miresmaeeli, Davoud Khorasani Zavareh, Hesam Seyedin, A comparative study: Accreditation of universities' disaster risk management for health promotion, Journal of Education and Health Promotion, 10.4103/jehp.jehp_590_22, 12, 1, (2023).